Novartis AG (Novartis AG) Price-to-Tangible-Book : (As of Apr. 24, 2024)

View and export this data going back to 1996. Start your Free Trial

What is Novartis AG Price-to-Tangible-Book?

As of today (2024-04-24), Novartis AG's share price is $98.35. Novartis AG's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $-1.74. Hence, Novartis AG's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Novartis AG's Price-to-Tangible-Book or its related term are showing as below:

During the past 13 years, Novartis AG's highest Price to Tangible Book Ratio was 1226.79. The lowest was 10.80. And the median was 14.88.

NVS's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.32
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Novartis AG's share price is $98.35. Novartis AG's Book Value per Sharefor the quarter that ended in Dec. 2023 was $22.83. Hence, Novartis AG's P/B Ratio of today is 4.31.

Novartis AG Price-to-Tangible-Book Historical Data

The historical data trend for Novartis AG's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis AG Price-to-Tangible-Book Chart

Novartis AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

1,244.48

47.71

Novartis AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Novartis AG's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Novartis AG's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novartis AG's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis AG's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Novartis AG's Price-to-Tangible-Book falls into.

Novartis AG Price-to-Tangible-Book Calculation

Novartis AG's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	98.35	/	-1.738
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Novartis AG Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Novartis AG's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis AG (Novartis AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis AG (NYSE:NVS) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

NVSEF:USA NVS N:Mexico NOVNz:UK 0QLR:UK NOTA:Germany NOTA:Germany NOVNEE:Switzerland NOVN:Switzerland N1VS34:Brazil NVS:Argentina

Address

Lichtstrasse 35, Basel, CHE, 4056

Website

https://www.novartis.com

Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.